ketoprofen/amitriptyline/oxymetazoline (OMS103HP)
/ Omeros
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 08, 2011
Omeros Corporation reports third quarter 2011 financial results
(PRNewswire)
- Currently enrolling patients in P3 programs and plan to report data next year for OMS302 in the first quarter and OMS103HP in mid-year
Anticipated P3 data • Pain
1 to 1
Of
1
Go to page
1